Related Experiment Videos

Sequence analysis of mitochondrial DNA in a mouse cell line resistant to chloramphenicol and oligomycin

Insights

Mitochondrial DNA mutations in mouse cells confer drug resistance. A novel mutation in the ATPase-6 gene, identified before drug selection, suggests a new model for mitochondrial mutation origins.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biochemistry

Background:

  • Mitochondrial DNA (mtDNA) mutations are implicated in various diseases.
  • Understanding the mechanisms of mtDNA mutation and drug resistance is crucial.

Purpose of the Study:

  • To characterize a drug-resistant mouse cell line (111-OB3).
  • To investigate the genetic basis of chloramphenicol and oligomycin resistance in mammalian cells.
  • To explore the origins of mitochondrial mutations.

Main Methods:

  • Isolation and characterization of a drug-resistant mouse L-cell line (111-OB3).
  • Analysis of mitochondrial DNA (mtDNA) using endonuclease EcoRI cleavage.
  • DNA sequencing to identify mutations in ATPase-6 and 16S rRNA genes.

Main Results:

  • The 111-OB3 cell line exhibits resistance to chloramphenicol and oligomycin.
  • Two mtDNA types were found, with one containing a novel EcoRI site in the ATPase-6 gene.
  • Sequencing revealed a valine to glutamic acid substitution in ATPase-6 and a nucleotide change in 16S rRNA.
  • The ATPase-6 mutation occurred prior to oligomycin selection.

Conclusions:

  • Oligomycin resistance in mammalian cells can be cytoplasmically inherited and linked to ATPase-6 alterations.
  • The findings support a model for the origin of mitochondrial mutations in mammalian cells, potentially arising before selective pressure.

Related Concept Videos